A1 Refereed original research article in a scientific journal

Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone




AuthorsGronlund J, Saari TI, Hagelberg NM, Neuvonen PJ, Olkkola KT, Laine K

PublisherWILEY-BLACKWELL

Publication year2010

JournalBritish Journal of Clinical Pharmacology

Journal name in sourceBRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Journal acronymBRIT J CLIN PHARMACO

Number in series1

Volume70

Issue1

First page 78

Last page87

Number of pages10

ISSN0306-5251

DOIhttps://doi.org/10.1111/j.1365-2125.2010.03653.x


Abstract
Drug interactions arising from CYP2D6 inhibition most likely have minor clinical importance for oral oxycodone if the function of the CYP3A4 pathway is normal. When both CYP2D6 and CYP3A4 pathways are inhibited, the exposure to oral oxycodone is increased substantially.



Last updated on 2024-26-11 at 11:36